References
- MochHCubillaALHumphreyPAReuterVEUlbrightTMThe 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumoursEur Urol201670110611926996659
- MochHAn overview of renal cell cancer: pathology and geneticsSemin Cancer Biol20132313922722066
- ThomasJSKabbinavarFMetastatic clear cell renal cell carcinoma: a review of current therapies and novel immunotherapiesCrit Rev Oncol Hematol201596352753326299335
- BanerjeePBasuADattaDGasserMWaaga-GasserAMPalSThe heme oxygenase-1 protein is overexpressed in human renal cancer cells following activation of the Ras-Raf-ERK pathway and mediates anti-apoptotic signalJ Biol Chem201128638335803359021808062
- SpechtEKaemmererDSängerJWirtzRMSchulzSLuppAComparison of immunoreactive score, HER2/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasmsHistopathology201567336837725641082
- LiuRPengJWangHOxysophocarpine retards the growth and metastasis of oral squamous cell carcinoma by targeting the Nrf2/HO-1 axisCell Physiol Biochem20184951717173330231242
- KehrerJPKlotzLOLars-OliverKFree radicals and related reactive species as mediators of tissue injury and disease: implications for healthCrit Rev Toxicol201545976579826610815
- RamadassMCatzSDMolecular mechanisms regulating secretory organelles and endosomes in neutrophils and their implications for inflammationImmunol Rev2016273124926527558339
- ScialòFFernández-AyalaDJSanzARole of mitochondrial reverse electron transport in ROS signaling: potential roles in health and diseaseFront Physiol20178242828701960
- SchieberMChandelNSROS function in redox signaling and oxidative stressCurr Biol20142410R453R46224845678
- Dinkova-KostovaATKazantsevAGActivation of Nrf2 signaling as a common treatment of neurodegenerative diseasesNeurodegener Dis Manag2017729710028534719
- TaguchiKMotohashiHYamamotoMMolecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolutionGenes Cells201116212314021251164
- NaHKSurhYJOncogenic potential of Nrf2 and its principal target protein heme oxygenase-1Free Radic Biol Med201467135336524200599
- ZhangDDMechanistic studies of the Nrf2-Keap1 signaling pathwayDrug Metab Rev200638476978917145701
- ShuklaKSonowalHSaxenaARamanaKVSrivastavaSKAldose reductase inhibitor, fidarestat regulates mitochondrial biogenesis via Nrf2/HO-1/AMPK pathway in colon cancer cellsCancer Lett20174112576328986187
- AmataEPittalàVMarrazzoARole of the Nrf2/HO-1 axis in bronchopulmonary dysplasia and hyperoxic lung injuriesClin Sci2017131141701171228667068
- ListerANedjadiTKitteringhamNRNrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapyMol Cancer20111013721489257
- McMahonMThomasNItohKYamamotoMHayesJDDimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a “tethering” mechanism: a two-site interaction model for the Nrf2-Keap1 complexJ Biol Chem200628134247562476816790436
- LuoYEgglerALLiuDLiuGMesecarADvan BreemenRBSites of alkylation of human Keap1 by natural chemoprevention agentsJ Am Soc Mass Spectrom200718122226223217980616
- TongKIKatohYKusunokiHItohKTanakaTYamamotoMKeap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition modelMol Cell Biol20062682887290016581765
- KobayashiAKangMIWataiYAkiraKMoon-IlKYorikoWOxi-dative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1Mol Cell Biol200626122116354693
- HuangPHeYCaoJUp-regulated Nrf2 in colorectal carcinoma and predicts poor prognosisInt J Clin Exp Med20171011034
- ZhengHNongZLuGCorrelation between nuclear factor E2-related factor 2 expression and gastric cancer progressionMed Sci Monit2015212893289926410168
- SolisLMBehrensCDongWNrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic featuresClin Cancer Res201016143743375320534738
- ShibataTKokubuAGotohMGenetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancerGastroenterology200813541358136818692501
- BaoLJJaramilloMCZhangZBNrf2 induces cisplatin resistance through activation of autophagy in ovarian carcinomaInt J Clin Exp Pathol2014741502151324817946
- BancosSBagloleCJRahmanIPhippsRPInduction of heme oxygenase-1 in normal and malignant B lymphocytes by 15-deoxy-delta(12,14)-prostaglandin J(2) requires Nrf2Cell Immunol20102621182720064636
- LuDYYehWLHuangSMTangCHLinHYChouSJOsteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cellsNeuro Oncol201214111367137823074199
- SrinivasanRRickettsCJSourbierCLinehanWMNew strategies in renal cell carcinoma: targeting the genetic and metabolic basis of diseaseClin Cancer Res2015211101725564569
- KimJKeumYSNrf2, a key regulator of antioxidants with two faces towards cancerOxid Med Cell Longev20162016217
- ZhaoHEguchiSAlamAMaDThe role of nuclear factorerythroid 2 related factor 2 (Nrf-2) in the protection against lung injuryAm J Physiol Lung Cell Mol Physiol20173122L155L16227864288
- ZhaoXDongWGaoYNovel indolyl-chalcone derivatives inhibit A549 lung cancer cell growth through activating Nrf-2/HO-1 and inducing apoptosis in vitro and in vivoSci Rep201771391928634389
- LiLTanJMiaoYLeiPZhangQROS and autophagy: interactions and molecular regulatory mechanismsCell Mol Neurobiol201535561562125722131
- LobodaADamulewiczMPyzaEJozkowiczADulakJRole of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanismCell Mol Life Sci201673173221324727100828
- ShibataTKokubuASaitoSNrf2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancerNeoplasia201113986487321969819